Optimal drug and behavior therapy for treatment-refractory schizophrenic patients

Robert Paul Liberman; Theodore Van Putten; Barringer D. Marshall; Jim Mintz; Linda Bowen; Timothy G. Kuehnel; Manickan Aravagiri; Stephen R. Marder

doi:10.1176/ajp.151.5.756

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients

Robert Paul Liberman, Theodore Van Putten, Barringer D. Marshall, Jim Mintz, Linda Bowen, Timothy G. Kuehnel, Manickan Aravagiri, Stephen R. Marder

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

Original language	English (US)
Pages (from-to)	756-759
Number of pages	4
Journal	American Journal of Psychiatry
Volume	151
Issue number	5
DOIs	https://doi.org/10.1176/ajp.151.5.756
State	Published - May 1994
Externally published	Yes

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.1176/ajp.151.5.756

Fingerprint Dive into the research topics of 'Optimal drug and behavior therapy for treatment-refractory schizophrenic patients'. Together they form a unique fingerprint.

Cite this

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. / Liberman, Robert Paul; Van Putten, Theodore; Marshall, Barringer D.; Mintz, Jim; Bowen, Linda; Kuehnel, Timothy G.; Aravagiri, Manickan; Marder, Stephen R.

In: American Journal of Psychiatry, Vol. 151, No. 5, 05.1994, p. 756-759.

Research output: Contribution to journal › Article › peer-review

@article{ed2b1f249fc64921a123cfdc24f166a3,

title = "Optimal drug and behavior therapy for treatment-refractory schizophrenic patients",

abstract = "Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.",

author = "Liberman, {Robert Paul} and {Van Putten}, Theodore and Marshall, {Barringer D.} and Jim Mintz and Linda Bowen and Kuehnel, {Timothy G.} and Manickan Aravagiri and Marder, {Stephen R.}",

year = "1994",

month = may,

doi = "10.1176/ajp.151.5.756",

language = "English (US)",

volume = "151",

pages = "756--759",

journal = "American Journal of Psychiatry",

issn = "0002-953X",

publisher = "American Psychiatric Association",

number = "5",

}

TY - JOUR

T1 - Optimal drug and behavior therapy for treatment-refractory schizophrenic patients

AU - Liberman, Robert Paul

AU - Van Putten, Theodore

AU - Marshall, Barringer D.

AU - Mintz, Jim

AU - Bowen, Linda

AU - Kuehnel, Timothy G.

AU - Aravagiri, Manickan

AU - Marder, Stephen R.

PY - 1994/5

Y1 - 1994/5

N2 - Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

AB - Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

UR - http://www.scopus.com/inward/record.url?scp=0028202507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028202507&partnerID=8YFLogxK

U2 - 10.1176/ajp.151.5.756

DO - 10.1176/ajp.151.5.756

M3 - Article

C2 - 8166320

AN - SCOPUS:0028202507

VL - 151

SP - 756

EP - 759

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 5

ER -